These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 2659269

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Further characterization of delta aroA delta virG Shigella flexneri 2a strain CVD 1203 as a mucosal Shigella vaccine and as a live-vector vaccine for delivering antigens of enterotoxigenic Escherichia coli.
    Noriega FR, Losonsky G, Wang JY, Formal SB, Levine MM.
    Infect Immun; 1996 Jan; 64(1):23-7. PubMed ID: 8557344
    [Abstract] [Full Text] [Related]

  • 7. Oral vaccination of monkeys with an invasive Escherichia coli K-12 hybrid expressing Shigella flexneri 2a somatic antigen.
    Formal SB, Hale TL, Kapfer C, Cogan JP, Snoy PJ, Chung R, Wingfield ME, Elisberg BL, Baron LS.
    Infect Immun; 1984 Nov; 46(2):465-9. PubMed ID: 6389344
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. An auxotrophic live oral Shigella flexneri vaccine: development and testing.
    Kärnell A, Stocker BA, Katakura S, Sweiha H, Reinholt FP, Cam PD, Trach DD, Lindberg AA.
    Rev Infect Dis; 1991 Nov; 13 Suppl 4():S357-61. PubMed ID: 2047663
    [Abstract] [Full Text] [Related]

  • 15. Immunity in shigellosis. II. Protection induced by oral live vaccine or primary infection.
    DuPont HL, Hornick RB, Snyder MJ, Libonati JP, Formal SB, Gangarosa EJ.
    J Infect Dis; 1972 Jan; 125(1):12-6. PubMed ID: 4550416
    [No Abstract] [Full Text] [Related]

  • 16. Stable Chromosomal Expression of Shigella flexneri 2a and 3a O-Antigens in the Live Salmonella Oral Vaccine Vector Ty21a.
    Dharmasena MN, Osorio M, Takeda K, Stibitz S, Kopecko DJ.
    Clin Vaccine Immunol; 2017 Dec; 24(12):. PubMed ID: 29046309
    [Abstract] [Full Text] [Related]

  • 17. Attenuated Shigella flexneri 2a Delta guaBA strain CVD 1204 expressing enterotoxigenic Escherichia coli (ETEC) CS2 and CS3 fimbriae as a live mucosal vaccine against Shigella and ETEC infection.
    Altboum Z, Barry EM, Losonsky G, Galen JE, Levine MM.
    Infect Immun; 2001 May; 69(5):3150-8. PubMed ID: 11292735
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of a polyvalent protein-polysaccharide dysentery oral vaccine.
    Zhang HM, Li YP, Song LH, Yu XL, Liu NH, Kong XE, Li L, Zhai YL.
    Chin Med J (Engl); 1987 May; 100(5):425-8. PubMed ID: 3115716
    [No Abstract] [Full Text] [Related]

  • 19. [Oral immunization with non-viable microorganisms or their antigens. 19. Field trials with polyvalent enteritis-oralvaccines (author's transl)].
    Raettig H.
    Zentralbl Bakteriol Orig A; 1978 Nov; 242(1):31-41. PubMed ID: 367002
    [No Abstract] [Full Text] [Related]

  • 20. Technological aspect of the production of live dysentery vaccines for oral administration.
    Denchev V, Nenkov P, Vitanov T, Sumerska T, Marinova S, Vassilev T, Panova I, Bratoeva M, Linde K.
    Acta Microbiol Hung; 1991 Nov; 38(2):121-6. PubMed ID: 1805499
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.